. Scientific Knowledge on the Subject: International standards for trial registration call for sufficient detail on outcomes measured in clinical trials. Analyses of clinical trial outcomes documented in intervention reviews and trial databases indicate a lack of sufficient detail to aid comparison and synthesis of findings. What this Study adds to the Field: Ventilation outcomes are not well defined and outcome time point measures are not consistent among trials. The outcomes reported generally fell into a number of domains that suggests the possibility of generating a core outcome set.
Abstract
Systematic reviews have considerable potential to provide evidence-based data to aid clinical decision-making. However there is growing recognition that trials involving mechanical ventilation lack consistency in the definition and measurement of ventilation outcomes, creating difficulties in combining data for meta-analyses. To address the inconsistency in outcome definitions, international standards for trial registration and clinical trial protocols published recommendations, effectively setting the 'gold standard' for reporting trial outcomes. In this Critical Care Perspective, we review the problems resulting from inconsistent outcome definitions and inconsistent reporting of outcomes (outcome sets Consistency in the measurement and reporting of trial outcomes is lacking. Williamson and colleagues noted that the most accessed and cited Cochrane reviews in 2009 all described inconsistencies in trial outcomes (2) . Two recent systematic reviews of the effectiveness of protocolized weaning highlighted inconsistencies in measurement time points for ventilation outcomes (3, 4) . Current international standards for trial registration (CONSORT, WHO registry) and the recent SPIRIT 2013 recommendations for writing clinical trial protocols stress that investigators should report the specific measurement variable and time frame for each outcome measure when registering trials (5-7). However, analysis of a cohort of records from the clinicaltrials.gov database indicated that 36% of trials registered a domain only and lacked definition of the specific measure, metric used or method of aggregation of results. (8) . Furthermore, outcomes included in trial protocols are not always reported in trial publications (9, 10) .
In addition to the need for consistency in outcome definitions, Williamson and colleagues called for the development and use of core outcome sets (2), defined as an "agreed, standardized collection of outcomes measured and reported in all trials for a specific clinical area" (11) . Agreement on a core outcome set should avoid problems associated with selective reporting of outcomes. The COMET (Core Outcome Measures in Effectiveness Trials) database has registered more than 260 references of planned work in developing core outcome sets and among them there are three studies exploring ventilation outcomes;
long-term outcomes in acute respiratory failure; and rehabilitation following critical illness (12).
Little is known about how ventilation outcomes are defined and measured. To investigate this we sought to: first, identify trials involving mechanically ventilated adults and children that reported ventilation outcomes and describe how these outcomes were reported; and second, explore how trials specifically evaluating ventilation interventions reported ventilation outcomes and whether these might reveal a core outcome set.
Review process
We aims, primary and secondary outcome measures and their definitions were extracted onto pre-piloted data extraction forms (see online data supplement, appendix 1). These forms were reviewed by the three authors to confirm inclusion: a fourth author (DMcA) acted as arbitrator.
Results
We included 66 reports of randomized trials and associated documentation (59 trial registrations; 34 electronic supplementary materials; 13 published protocols) ( Figure 1) .
Interventions addressed management of ventilation; sedation; physiotherapy; nutrition; renal/fluid management; medications and infection prevention. The 66 trials reported 30 different primary outcomes. Primary outcomes reported by more than 1 trial and secondary outcomes reported by more than 10 trials are shown in Figure 2 .
Nine ventilation outcomes were reported across included trials reflecting measures of ventilator dependence or occurrence of events (typically adverse outcomes) ( Table 1) . Table 2) . Three trials reporting weaning duration as a secondary outcome (24, 62, 76) and only one provided a definition (24) . When reintubation was reported as a trial outcome (4 trials), follow-up was measured at 24-hours (73), 48-hours (49, 61) or 7-days (32) . When reintubation was recorded as an adverse event (4 trials) (31, 40, 55, 71) , the follow-up period within which this was measured was not provided.
Outcomes reported in trials specifically evaluating a ventilation intervention
Twelve trials tested a ventilation intervention including sedation and ventilation weaning methods (20, 30, 31, 43, 44, 49, 68) ; ventilator modes (27, 78) ; automated systems to facilitate ventilator weaning (61, 64) ; and early non-invasive ventilation following invasive ventilation (32) . Primary and secondary outcomes reported in these trials are presented in There was considerable variation in measuring primary outcomes. Ventilation trials reported either duration of mechanical ventilation or ventilator-free days, but not both. Start and endpoints are shown in Table 3 . In secondary outcomes, mortality was reported for different follow up periods that included: ICU (20, 49, 68, 78) ; hospital (20, 68, 78); 28-day (31, 64); 30-day (30); 90-day (31) ; and prior to ventilator separation potential and extubation (61) . One trial did not define the follow up period (27) and one trial did not measure mortality (43) . Two trials measured survival, at 1-year (31) and at an undefined time point (32) .
Discussion
We found substantial variation in the outcome sets used. Outcome definitions differed between trials, often measuring different time points and different follow up periods.
Furthermore, a large number of trials lacked detail in their outcome definitions.
It is important to highlight the effect related to the competing risk of death in using duration of ventilation as an outcome measure. Various statistical methods have tried to address this issue. Egleston and colleagues(79) point out that by using a basic approach of examining outcomes in survivors only it is possible that a harmful intervention will increase mortality in a vulnerable population. These remaining healthier survivors may have a reduced duration of ventilation giving the impression that the intervention has a beneficial effect. (79) Therefore it is important to consider the duration of ventilation as an outcome in the context of mortality. Measuring ventilator-free days (i.e. a composite outcome of mortality and duration of ventilation) is one method to address competing risks. (80) Our work has demonstrated that ventilator-free days are often poorly defined or not reported.
Cause specific hazard models that fail to take into account the competing event (death) results in the patient being censored from the analysis and may falsely make the intervention appear beneficial. The common domains that are addressed give rise to the possibility of obtaining agreement on outcome definitions and a core outcome set. A core outcome set would not restrict trialists from measuring additional outcomes, but would overcome problems of variability in outcome selection, measurement and reporting thereby enhancing valid comparisons across trials. To address this, we are undertaking a study that will use the Delphi technique to achieve international consensus on core outcome definitions and a core outcome set for use in trials involving mechanical ventilation (http://www.cometinitiative.org/studies/details/292?result=true). We will liaise closely with the International Forum for Acute Care Trialists (InFACT) and the Delphi panel will draw upon relevant stakeholders including patient groups, professional societies, clinical trial groups, and industry.
Limitations
Our search for trials was restricted to a short, but recent, time period and a small number of journals. It does not provide a full comprehensive overview of ventilation outcomes in trials across a longer time period and a wider range of journals; however, we are confident that we have presented sufficient data to demonstrate significant variability in outcome reporting in recent trials accepted for publication in high impact journals.
Conclusion
We show substantial variation in the choice of outcome measures and their definition in randomized trials evaluating interventions likely to influence the duration of ventilation. We anticipate the recent SPIRIT 2013 statement (7) outlining guidance for reporting clinical trial protocols will help investigators provide clear definitions enabling more appropriate comparisons. Expert consensus on, and implementation of, standardized outcome definitions and core outcome sets is fundamental to reducing bias when comparing effects across trials. (57) Not specifically stated (26, 65, 69, 70, 76) Day 28 and 90 (54) Not specifically stated (72) Key: IMV, invasive mechanical ventilation; NIV, noninvasive mechanical ventilation; SBT, spontaneous breathing trial; UAB, unassisted breathing. Some trials measured more than one endpoint. Table 3 Start and end point variability for ventilation outcomes in 12 ventilation trials
Start point Endpoint

Duration of mechanical ventilation
Commencement of IMV(20, 30) 1 st extubation(30, 61, 64) Intubation (43, 61) Successful extubation(61) Randomization (39, 76, 77) Extubation or a trache mask for 48 Key: IMV, invasive mechanical ventilation; NIV, noninvasive mechanical ventilation; SBT, spontaneous breathing trial. Some trials measured more than one start and endpoint.
